Undoubtedly, we are in the midst of a mental health crisis, with the torment of mental health disorders affecting everyone, whether personally, within our families, or among our friends. The rates of suicide are staggering and unacceptable.
One remarkable aspect of ketamine therapy is its ability to eradicate intrusive negative thoughts nearly instantaneously. Ketamine therapy is a type of mental health treatment that has been demonstrated to effectively and rapidly address suicidal ideation, which is the thought of taking one's own life.
I have witnessed firsthand how suicidal ideation is managed in the emergency department within hospitals, I am convinced that there are more effective tools than the current standard of care offers. I envision a future where ketamine infusions are easily accessible on the front lines, offering assistance to those in dire need and making them available to individuals who may not have the financial means to afford infusions in an outpatient setting.
Today, we will explore how ketamine therapy can offer healing to those with overwhelming negative self-talk and thoughts of self-harm.
The management of individuals at risk of suicide involves several key components:
While the aforementioned represents the standard approach for addressing acute suicidal crises in the emergency department, I have personally witnessed the less-than-ideal reality. Patients are placed on a "psychiatric hold" in a section of the emergency department alongside individuals facing various psychiatric emergencies, including acute psychosis. This environment can be chaotic, marked by confrontations, noise, fluorescent bright lights, and other disturbances—far from the tranquil setting conducive to easing someone out of an acute suicidal state.
Subsequently, patients are sedated, often in conjunction with other antidepressants that have a delayed onset of action. Upon awakening, they may be offered unappetizing food like a bologna sandwich while awaiting a more in-depth psychiatric evaluation by the on-call psychiatrist. It's important to note that this awaited relief is far from expedited, with patients frequently enduring waits sometimes as long as 24 hours. Understandably, this prolonged waiting period can leave patients feeling hopeless, frustrated, and occasionally reclassified as "low risk," which allows them to leave, potentially prematurely. In other instances, they simply choose to leave against medical advice—a decision that can be difficult to fault given the circumstances.
Intravenous ketamine has shown promise as a rapid and effective treatment for suicidal ideation. Clinical studies have shown that a single ketamine infusion can reduce suicidal thoughts within just one hour. Those receiving ketamine achieved full remission of suicidal ideas at a rate of 63% by day three, and remission rates remained high (70%) at week six. It is worth noting that the nasal form of ketamine, Esketamine, is FDA-approved for unipolar major depression that includes acute suicidal ideation or behavior. However, it is important to highlight that there is a lack of high-quality studies demonstrating Esketamine's ability to prevent suicide or suicidal behavior, and the evidence supporting its effectiveness in improving suicidal ideation is limited. Intravenous ketamine allows for a more consistent and rapid response and is thus the preferred from of ketamine for suicidal ideation.
One of the notable aspects of ketamine's effectiveness is its speed of action. Unlike traditional antidepressants that can take weeks to start working, ketamine can often produce a rapid reduction in suicidal thoughts within hours or even minutes after administration. This quick onset of action can be crucial in emergency situations where immediate relief is needed to prevent self-harm or suicide attempts.
It never ceases to amaze me how ketamine's immediate effects can eliminate negative self-talk in my patients. Ketamine's impact is so strikingly evident that one can't help but feel immense hope and appreciation for, what I believe, is a gift in the field of mental health. A recurring experience after a ketamine infusion includes a feeling of hope and self-love. Witnessing the ‘dark cloud’ lift from my patients is an experience I hold dear. As one former patient put it best,
"Love is everything. I'm back! I'm going to be okay, no, I'm going to be more than just okay."
What I often observe with my patients after their initial evaluation is that they are often well-informed about what they "should do" to feel better, yet they lack the energy, motivation, and willpower to help themselves. They feel stuck and need something to trigger a significant shift in their thought processes regarding their current situation and outlook on life. Ketamine offers them that stark change in perception and a gleaming glimmer of hope that they will be more than "just okay."
My hope is that ketamine will be offered as an initial treatment approach during acute suicidal crises, as witnessed on the frontlines in the emergency department. I envision a future where suicidal patients receive ketamine infusions instead of being held against their will and sedated as a form of ‘help’.
Secondly, I hope for a future where ketamine is accessible to more than just those who can afford it in the outpatient setting. People in lower socioeconomic statuses suffer just as much, if not more, than those with expendable income. We need to think on a larger scale and consider how improvements in mental health for the masses will have a positive impact on humanity.
As we approach the end of the year, let's take a closer look at ketamine as a valuable tool for tackling this affliction that affects millions. Ketamine provides a rapid and effective means to eliminate negative self-talk and thoughts of self-harm. However, it is crucial for individuals experiencing such thoughts to seek comprehensive care from mental health professionals who can assess their unique needs and provide appropriate interventions. Please consider Innerbloom and our team as a source of hope for a brighter future filled with self-love.
About the Author
Dr. Ray Rivas, a former general and trauma surgeon with over a decade of experience utilizing ketamine, became a ketamine therapy specialist to treat mental health and pain after witnessing its profound impact on his hospital trauma patients and his own mental health. As the founder and medical director of Innerbloom Ketamine Therapy in San Luis Obispo, California, Dr. Rivas applies his extensive medical expertise to provide safe, evidence-based ketamine treatments for mood disorders, including depression, anxiety, PTSD, and chronic pain. His passion lies in helping patients find relief and rediscover hope through personalized, compassionate care.
Disclaimer: All content on this website, including (but not limited to) this statement, news, blog post, article, testimonial, or FAQ is not medical advice and should not be considered as such. This website cannot diagnose or treat any medical condition. Only a licensed medical professional who is familiar with you and your medical history can do that. Therefore, we cannot be responsible or liable for any actions taken by those who access our website or rely on its content. Please refer to the Terms & Conditions for more information.